Search for Clinical Trial Results
Graft vs Host Disease - 26 Studies Found
Status | Study |
Completed |
Study Name: CC-4047 (Pomalidomide) for Graft vs. Host Disease Condition: Graft vs Host Disease Date: 2008-10-07 Interventions: Drug: CC-4047 Other Name: Pomalidomide |
Completed |
Study Name: Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD) Condition: Graft vs Host Disease Date: 2005-09-04 Interventions: Procedure: intra-arterial treatment |
Completed |
Study Name: Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease Condition: Graft vs Host Disease Date: 2006-10-12 Interventions:
|
Completed |
Study Name: Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD) Condition: Graft vs Host Disease Date: 2010-05-05 Interventions: Genetic: Mesenchymal stromal cells Mesenchymal stromal cells (MSC) intravenous infusion at least two fix |
Completed |
Study Name: Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease Condition: Graft vs Host Disease Date: 2012-11-25 Interventions:
|
RECRUITING |
Study Name: Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Condition: Graft vs Host Disease Date: 2024-05-19 Interventions: Pacritinib will be given as 100 mg or 200 mg tablets to be taken orally twice daily (12 hours apart) on days 1-28 of a 28 day cycle.Morning and |